Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247399 | SCV000312487 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000713739 | SCV000844368 | benign | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311387 | SCV000846182 | benign | Inborn genetic diseases | 2016-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000713739 | SCV001717505 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713739 | SCV001860548 | benign | not provided | 2018-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001815264 | SCV002062175 | benign | Developmental and epileptic encephalopathy, 18 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000713739 | SCV005288411 | benign | not provided | criteria provided, single submitter | not provided |